MSN and neoplasm: The muscle invasive tumour, however, showed a basal subtype (higher expression of CDH3, CD44, KRT5 and KRT6A) and likewise high aggressiveness (higher expression of KPNA2, BIRC5, CDC25B, COL4A1, and MSN).